Market Size – USD 11,057.7 million in 2018, Market
Growth - CAGR of 13.6%, Market Trends – Product launches and research for
advanced Histology and Cytology
According to the recent analysis of Reports and Data, the
global histology and
cytology market was valued at USD 11,057.7 million in 2018 and
is expected to reach USD 30,543.4 million by the year 2026, exhibiting a CAGR
of 13.6%. Histology and Cytology procedures are related to the diagnosis of
diseases and other conditions. Histology is the study of human tissues, which
includes structure and function, whereas cytology is the study of human cells.
Histology and cytology market had experienced a huge growth with regards to
healthcare industries as several fatal diseases can be diagnosed through these
clinical studies.
Currently, use of molecular techniques is a widely accepted method
in histology and cytology as an enabler of morphology for diagnosing and
prognosing. Moreover, the study of markers of therapeutic response has been
helpful in some types of neoplasms for diagnosing cancer. There are numerous
advantages in the use of cytological material to perform molecular studies:
ease of obtaining fresh sample, ability to check the quality of the sample
immediately after draw and better preservation of DNA and RNA.
 |
| Histology and Cytology Market | Reports and Data |
The possibility of using genomic and proteomic research in small
quantities of sample obtained by fine-needle aspiration (ENA) can minimize
invasive procedures and allow the monitoring of cancer, thereby increasing the
demand of histology and cytology procedures. PCR, microarrays, proteomic and
other sequencing methodologies are now being validated in cytological samples.
Proper specimen processing is of utmost importance in maintaining morphology
and nucleic acid integrity. The role of the cytopathologist is mandatory in the
collection and selection of cells. Histopathology evaluation basically compares
diseased or experimentally altered tissues with matching sample from healthy or
control counterparts. Therefore, it is very important to rigor-ously
standardize every histology process (i.e., specimen sam-pling, trimming,
embedding, sectioning, and staining). Cytology allows the identification of
malignancy from a small quantity of cells. Cervical Pap smears are the most
widely accepted example of this kind of testing and have dramatically reduced
the incidence of cervical carcinoma.
Cytology provides patients a minimally or non-invasive means of
obtaining samples and allows analysis of samples such as exfoliated cells in
sputum and urine, and pleural, pericardial, cyst fluids. Fine needle
aspiration provides cell samples from small lesions, and under image guidance
from inaccessible sites such as the lung, head of pancreas and para-aortic
lymph nodes. Specimens are often very small and to obtain maximum utility, the
process should be performed by trained technicians and using proper and
high-end cytology and histology equipment. Growing awareness about the
screening of cancer and technological advancements in the cell and tissue
studies are likely to boost the demand during the forecast period. An
increasing number of well-equipped clinical laboratories in developing
countries and favorable reimbursement for cancer screening and laboratory tests
are likely to propel market growth. Advancements in cytology and histology save
time for pathologists, making the service more cost-effective. Low cost, high
sensitivity, and adequate specificity associated with cytology examination
procedure will further bolster the histology and cytology market growth.
Efficient testing of samples can result in cost-saving and faster outcomes to
patients and increasing awareness of individuals about their health. Stringent
regulation is one of the key factors for hampering the growth of histology and
cytology market.
Further key findings from the
report suggest
- Histology and cytology market had
experienced a huge growth in the healthcare industry as several fatal
diseases can be diagnosed through these clinical studies
- Roche launched the VENTANA DP 200
slide scanner which is a high-speed slide scanner for digital pathology in
March 2018. It reduces workflow errors and improves image quality. Such
product launches are expected to drive histology and cytology market
To
identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/histology-and-cytology-market
- Cytology testing attributed to
large disease prevalence and adoption of the test for cervix screening.
The segment can maintain its leading position during the forecast period
due to the recent entry of various tests and advantages over histology
such as faster analysis and cost-effectiveness
- Flow Cytometry sub-segment was
expected to show the maximum CAGR during the forecast period within the
test type segmentation of the histology and cytology. This segment is used
to detect and measure characteristics of cell mainly used in laboratories
which contribute to the market growth of this product segment
- The histology and cytology market
will prove advantageous to the Asia-Pacific region to a great extent. It’s
CAGR was the highest amongst all regions during the forecast period.The
major factor driving the growth of this market is the huge population density
in countries like India and China and increasing awareness about these
tests
- In September 2018, Phillips
launched computational pathology software, Tissue Mark, for automated
ovarian and prostate tumor detection, which provides doctors and lab
technicians with an effective histology and cytology diagnosis tool
- Some of the key players operating
in the histology and cytology market are Abbott Laboratories; Becton
Dickinson and Company; BrandTech Scientific, Hoffmann-La Roche Ltd.;
Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo
Fisher Scientific, Inc.; Southwest Precision Instruments, and Trivitron
Healthcare
For this report, Reports and Data have segmented the Histology and
cytology market based on type, disease type, treatment type, test type, end-use
and region:
Type of Examination in Histology and Cytology market (Revenue, USD
Million; 2016–2026)
- Cytology
- Cervical Cancer
- Breast Cancer
- Other Cancers
- Histology
Test Type in Histology and Cytology market (Revenue, USD Million;
2016–2026)
- Microscopy methods
- Cytochemistry and histochemistry
- Immunohistochemistry and
Immunofluorescence
- Flow cytometry
- Molecular genetic methods
- Cytogenic tests
- karyotyping
- fluorescent in situ
hybridization (FISH)
- Polymerase chain reaction
- Others
End-use of Histology and Cytology market (Revenue, USD Million;
2016–2026)
- Hospitals/Clinics
- Biopharmaceuticals companies
- Academia
- Other end-users
Regional Outlook of Histology and Cytology market (Revenue in USD
Million; 2016–2026)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About
Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
No comments:
Post a Comment